A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Levothyroxine and the Influence of Co-administered Tablets on the Pharmacokinetics of Semaglutide Administered Orally in Healthy Subjects.

NCT02920385 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Healthy

Interventions

DRUG: Semaglutide
DRUG: SNAC
DRUG: Levothyroxine
DRUG: Placebo

Sponsor

Novo Nordisk A/S